Market Rally Aims for “Cloud Nine,” Bronfman's Paramount Bid, Eli Lilly CEO on Weight-Loss Drug 8/20/24

Carl Quintanilla and Jim Cramer led off the show by delving into the broadening market rally, as the S&P 500 and Nasdaq aim for a ninth consecutive day of gains. David Faber called into the show with reporting on Edgar Bronfman's bid to acquire Paramount Global. Eli Lilly CEO David Ricks joined the program "First on CNBC"  to discuss the pharma giant’s weight-loss drug: The company says it cut diabetes risk by 94% in a late-stage trial. Also in focus: Nvidia and the "Mag 7" post-selloff surge, earnings from the likes of Lowe's and Palo Alto Networks, another setback for Boeing, the Alaska Air-Hawaiian Airlines merger clears an antitrust hurdle. Squawk on the Street Disclaimer

Om Podcasten

The opening hour of CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer and David Faber is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential Chief Executive Officers and greatest market minds.